시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 의약품 콜드체인 포장 시장 보고서(2025년)
Pharmaceutical Cold Chain Packaging Global Market Report 2025
상품코드 : 1811001
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,444,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,314,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,184,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 의약품 콜드체인 포장 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 15.5%로 확대되어 483억 4,000만 달러로 성장할 것으로 예상됩니다. 예측기간 동안 예상되는 성장은 mRNA 기반과 세포 및 유전자 치료의 확대, 생물제제와 맞춤형 의료 개발 증가, 세계적인 기온 변동폭 확대, 의약품 제조와 공급망의 지속적인 세계화, 고령화 인구 증가 등에 기인하고 있습니다. 이 기간에 예상되는 주요 동향으로는 IoT 대응 센서를 갖춘 스마트 포장의 채용, 추적성과 온도 추적을 위한 블록체인 기술의 이용, 단열성 향상을 위한 상변화물질(PCM)의 응용, 온도 편차의 예측 관리를 위한 AI와 머신러닝의 도입, 합리화된 콜드체인 물류를 위한 소프트웨어 플랫폼의 통합 등이 있습니다.

생물제제와 백신 수요 증가가 의약품 콜드체인 포장 시장의 확대를 견인할 것으로 예측됩니다. 생물 제제는 다양한 질병의 치료에 사용되는 생물 유래 치료 제품이며, 백신은 특정 감염에 대한 면역을 구축하도록 설계되었습니다. 암, 자가면역질환, 당뇨병 등의 질환에 대해 표적을 좁힌 효과적인 치료법을 제공하기 위해 만성질환의 만연이 진행되고 있는 것이 이러한 치료에 대한 수요 증가로 이어지고 있습니다. 콜드체인 포장은 생물 제제 및 백신의 보관 및 운송 중에 필요한 온도 범위를 유지하고 제조에서 투여까지의 안정성, 효력, 안전성을 확보하는데 중요한 역할을 합니다. 예를 들어, 2025년 6월, GOV.UK는 영국 전역에서 MMR1 백신의 초기 접종률이 1분기에 비해 상승했다고 보고했습니다. 잉글랜드 동부, 런던, 남서부에서는 각각 0.5포인트 증가, 남동부와 중서부에서는 0.1포인트 증가, 북동부, 요크셔, 북서부에서는 0.2포인트 증가했습니다. 이 추세는 온도에 민감한 의약품의 안전한 유통을 지원하는 효과적인 콜드체인 포장 솔루션에 대한 필요성 증가를 강조합니다.

의약품 콜드체인 포장 시장의 주요 기업은 친환경 온도 제어 포장 솔루션을 도입하여 기술의 진보를 중시하고 있습니다. 이러한 지속 가능한 솔루션은 재활용 가능, 생분해성 또는 재사용 가능한 재료를 사용하여 환경에 미치는 영향을 줄이면서 섬세한 제품의 온도를 유지하도록 설계되었습니다. 2025년 4월 미국에 본사를 둔 포장업체인 Cold Chain Technologies, LLC는 제약산업용 섬유 기반 플라스틱을 사용하지 않는 온도 제어 포장 솔루션인 TailorTemp를 출시했습니다. 재활용 가능한 골판지만으로 구성된 TailorTemp는 전통적인 EPS 용기를 대체하는 친환경 제품으로 자리 잡고 있습니다. 설계는 열전도 실험실과 공동으로 개발된 컴퓨터 기반 파라메트릭 알고리즘에 의해 유도되어 포장 치수, 단열재 및 냉각제의 필요성을 고객별로 최적화합니다. 필요한 온도를 최대 36시간까지 유지할 수 있는 이 솔루션은 신속한 프로토타입 및 검증을 지원하며 플랫팩 운송을 통해 지속가능성과 물류 효율을 더욱 향상시킵니다. 콜드체인 물류의 성능과 능력을 높이기 위해 지속적인 연구가 진행되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Pharmaceutical cold chain packaging involves the specialized design and production of insulated and temperature-controlled packaging systems to protect the integrity, stability, and safety of temperature-sensitive pharmaceutical products during storage and transportation. This packaging is essential for preserving the effectiveness of vaccines, biologics, insulin, and other temperature-sensitive medications by maintaining specific thermal conditions throughout the entire supply chain-from the manufacturer to the end user.

The primary types of products in pharmaceutical cold chain packaging include insulated shippers, insulated containers, gel packs and ice packs, phase change materials, and dry ice. Insulated shippers are containers engineered to sustain a consistent internal temperature while transporting sensitive pharmaceutical items. These shippers are available in formats such as active and passive packaging and are distributed through various channels including direct sales, distributors, online platforms, retail pharmacies, and cold chain logistics providers. They are utilized in a range of applications, such as vaccines, biologics, pharmaceuticals, clinical trials, and laboratory samples, and serve diverse end users, including biopharmaceutical companies, clinical research organizations, hospitals, research institutes, logistics and distribution firms, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The pharmaceutical cold chain packaging market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical cold chain packaging market statistics, including pharmaceutical cold chain packaging industry global market size, regional shares, competitors with a pharmaceutical cold chain packaging market share, detailed pharmaceutical cold chain packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical cold chain packaging industry. This pharmaceutical cold chain packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical cold chain packaging market size has grown rapidly in recent years. It will grow from $23.44 billion in 2024 to $27.14 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth during the historical period can be attributed to the expansion of vaccine production, the rise in global pharmaceutical trade, increased investment in healthcare logistics, the growth of clinical trials necessitating international shipping, and the development of cold chain infrastructure in emerging markets.

The pharmaceutical cold chain packaging market size is expected to see rapid growth in the next few years. It will grow to $48.34 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The anticipated growth in the forecast period can be credited to the expansion of mRNA-based and cell and gene therapies, the increasing development of biologics and personalized medicine, greater variability in global temperatures, the continued globalization of pharmaceutical manufacturing and supply chains, and the growth of the aging population. Key trends expected during this period include the adoption of smart packaging equipped with IoT-enabled sensors, the use of blockchain technology for traceability and temperature tracking, the application of phase change materials (PCMs) for improved insulation, the implementation of AI and machine learning for predictive management of temperature excursions, and the integration of software platforms for streamlined cold chain logistics.

The growing demand for biologics and vaccines is expected to drive the expansion of the pharmaceutical cold chain packaging market. Biologics are therapeutic products derived from living organisms used to treat a range of diseases, while vaccines are designed to build immunity against specific infections. The increasing prevalence of chronic illnesses has contributed to the rising demand for these treatments, as they offer targeted and effective therapies for conditions such as cancer, autoimmune diseases, and diabetes. Cold chain packaging plays a critical role in maintaining the required temperature range during the storage and transport of biologics and vaccines, ensuring their stability, potency, and safety from production to administration. For example, in June 2025, GOV.UK reported an increase in coverage for the first dose of the MMR1 vaccine across all UK regions compared to the first quarter of the year. The East of England, London, and the Southwest each saw an increase of 0.5 percentage points, while the Southeast and Midlands recorded smaller increases of 0.1 percentage points, and the Northeast, Yorkshire, and Northwest experienced 0.2 percentage point increases. This trend underscores the rising need for effective cold chain packaging solutions to support the safe distribution of temperature-sensitive pharmaceuticals.

Leading companies in the pharmaceutical cold chain packaging market are emphasizing technological advancements by introducing eco-friendly, temperature-controlled packaging solutions. These sustainable solutions are designed to preserve the temperature of sensitive products while reducing environmental impact through the use of recyclable, biodegradable, or reusable materials. In April 2025, Cold Chain Technologies, LLC, a US-based packaging firm, launched TailorTemp, a fiber-based, plastic-free temperature-controlled packaging solution tailored for the pharmaceutical industry. Constructed entirely from recyclable corrugated cardboard, TailorTemp is positioned as an environmentally responsible alternative to traditional EPS containers. The design is guided by a computer-based parametric algorithm, developed in collaboration with a thermal transfer laboratory, which optimizes the packaging's dimensions, insulation, and coolant needs for each client. Capable of maintaining required temperatures for up to 36 hours, the solution supports rapid prototyping and validation, with flat-pack shipping further improving its sustainability and logistical efficiency. Continued research is being conducted to enhance its performance and capabilities in cold chain logistics.

In October 2024, Cold Chain Technologies expanded its global capabilities through the acquisition of Tower Cold Chain, a UK-based provider of advanced, reusable passive temperature-controlled packaging solutions for the pharmaceutical, biotech, and life sciences sectors. The acquisition, made for an undisclosed sum, is intended to broaden Cold Chain Technologies' product portfolio and international reach. By incorporating Tower Cold Chain's expertise and innovative solutions, the company aims to strengthen its global service network and enhance its ability to deliver sustainable, compliant, and effective packaging for temperature-sensitive pharmaceutical products.

Major players in the pharmaceutical cold chain packaging market are Sonoco Products Company, Sealed Air Corporation, Biobase Group, Csafe Global LLC, Cryoport Systems LLC, Cold Chain Technologies LLC, Topa Thermal BV, Envirotainer AB, Haier Biomedical Co. Ltd., Peli BioThermal Limited, SkyCell AG, Cryopak Industries Inc., Sofrigam SAS, Intelsius LLC, Softbox Systems Ltd., Inmark Global Holdings LLC, Insulated Products Corporation, Chill-Pak, CoolPac Pty Ltd, Practical Packaging Solutions Inc., The Wool Packaging Solutions Limited, Thermal Energy Service Solutions Pvt. Ltd., and Thermal Packaging Solutions Ltd.

North America was the largest region in the pharmaceutical cold chain packaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical cold chain packaging report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical cold chain packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical cold chain packaging market consists of sales of insulated shipping containers, phase change materials (PCMs), temperature data loggers, and refrigerated boxes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Cold Chain Packaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical cold chain packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pharmaceutical cold chain packaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical cold chain packaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Pharmaceutical Cold Chain Packaging Market Characteristics

3. Pharmaceutical Cold Chain Packaging Market Trends And Strategies

4. Pharmaceutical Cold Chain Packaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Cold Chain Packaging Growth Analysis And Strategic Analysis Framework

6. Pharmaceutical Cold Chain Packaging Market Segmentation

7. Pharmaceutical Cold Chain Packaging Market Regional And Country Analysis

8. Asia-Pacific Pharmaceutical Cold Chain Packaging Market

9. China Pharmaceutical Cold Chain Packaging Market

10. India Pharmaceutical Cold Chain Packaging Market

11. Japan Pharmaceutical Cold Chain Packaging Market

12. Australia Pharmaceutical Cold Chain Packaging Market

13. Indonesia Pharmaceutical Cold Chain Packaging Market

14. South Korea Pharmaceutical Cold Chain Packaging Market

15. Western Europe Pharmaceutical Cold Chain Packaging Market

16. UK Pharmaceutical Cold Chain Packaging Market

17. Germany Pharmaceutical Cold Chain Packaging Market

18. France Pharmaceutical Cold Chain Packaging Market

19. Italy Pharmaceutical Cold Chain Packaging Market

20. Spain Pharmaceutical Cold Chain Packaging Market

21. Eastern Europe Pharmaceutical Cold Chain Packaging Market

22. Russia Pharmaceutical Cold Chain Packaging Market

23. North America Pharmaceutical Cold Chain Packaging Market

24. USA Pharmaceutical Cold Chain Packaging Market

25. Canada Pharmaceutical Cold Chain Packaging Market

26. South America Pharmaceutical Cold Chain Packaging Market

27. Brazil Pharmaceutical Cold Chain Packaging Market

28. Middle East Pharmaceutical Cold Chain Packaging Market

29. Africa Pharmaceutical Cold Chain Packaging Market

30. Pharmaceutical Cold Chain Packaging Market Competitive Landscape And Company Profiles

31. Pharmaceutical Cold Chain Packaging Market Other Major And Innovative Companies

32. Global Pharmaceutical Cold Chain Packaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Cold Chain Packaging Market

34. Recent Developments In The Pharmaceutical Cold Chain Packaging Market

35. Pharmaceutical Cold Chain Packaging Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기